An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer

Kalkidan Ayele; Hiroaki Wakimoto; Dipongkor Saha

doi:10.1016/j.ymthe.2024.08.007

An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer

Kalkidan Ayele
, Hiroaki Wakimoto
, Dipongkor Saha

California Northstate University
Massachusetts General Hospital

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	2810-2813
Number of pages	4
Journal	Molecular Therapy
Volume	32
Issue number	9
DOIs	https://doi.org/10.1016/j.ymthe.2024.08.007
State	Published - Sep 4 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ymthe.2024.08.007

Cite this

@article{9579dbaa0430458da9dd10bf3f531da9,

title = "An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer",

author = "Kalkidan Ayele and Hiroaki Wakimoto and Dipongkor Saha",

year = "2024",

month = sep,

day = "4",

doi = "10.1016/j.ymthe.2024.08.007",

language = "English",

volume = "32",

pages = "2810--2813",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "9",

}

TY - JOUR

T1 - An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer

AU - Ayele, Kalkidan

AU - Wakimoto, Hiroaki

AU - Saha, Dipongkor

PY - 2024/9/4

Y1 - 2024/9/4

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85203475170&origin=inward

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85203475170&origin=inward

U2 - 10.1016/j.ymthe.2024.08.007

DO - 10.1016/j.ymthe.2024.08.007

M3 - Article

C2 - 39178849

SN - 1525-0016

VL - 32

SP - 2810

EP - 2813

JO - Molecular Therapy

JF - Molecular Therapy

IS - 9

ER -

An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer

UN SDGs

Access to Document

Other files and links

Cite this